<DOC>
	<DOCNO>NCT02945449</DOCNO>
	<brief_summary>Intracavernous injection Wharton jelly Mesenchymal stem cell treatment erectile dysfunction diabetic patient .</brief_summary>
	<brief_title>Use Wharton Jelly Erectile Dysfunction</brief_title>
	<detailed_description>This study conduct Cell Therapy Center ( CTC ) , Jordan , fifteen male patient range 25-65 year diagnose erectile dysfunction select . This diagnosis base medical history , validated questionnaire , physical examination , laboratory test specific diagnostic test . The patient follow clinical assessment , laboratory investigation well Doppler ultrasound . The investigator hypothesize intracavernous injection stem cell facilitate recovery erectile function result satisfy clinical outcome patient .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>1 . Adult male patient range 25 65 year . 2 . History chronic erectile dysfunction least six month . 3 . Baseline international index erectile function ( IIEF ) score &lt; 26 . 4 . Not interested able use phosphodiesterase type 5 inhibitor ( PD5i ) drug therapy willing forgo thesis treatment first 6 month period follow study treatment . 5 . Body Mass Index 2030 . 6 . Willing provide write informed consent , complete questionnaire , available baseline treatment follow examination require protocol . 1 . Current urinary tract bladder infection . 2 . Clinical/Laboratory evidence transmissible disease . 3 . Clinically evident penile anatomical deformity ( e.g. , Peyronie 's disease ) history priapism . 4 . Skin irritation , infection , wound , sore disruption immediate area skin entry penile injection . 5 . Current previous malignancy . 6 . Use non study treatment erectile function within 4 week study treatment . 7 . Lack willingness continue 6 month study treatment . 8 . Any previous penile implant penile vascular surgery . 9 . Uncontrolled hypertension hypotension ( systolic blood pressure &gt; 170 &lt; 90 mm Hg , diastolic blood pressure &gt; 100 &lt; 50 mm Hg ) . 10 . Reported unstable cardiovascular disease ( e.g. , unstable angina , myocardial infarction within past 6 month , cardiac failure lifethreatening arrhythmia , congestive heart failure ) symptomatic postural hypotension within 6 month screen . 11 . Bleeding clot disorder , use anticoagulant therapy . 12 . Lab value complete blood count ( CBC ) , prothrombin time ( PT ) / partial thromboplastin time ( PTT ) / international normalize ratio ( INR ) , alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) creatinine fall outside normal lab value . 13 . Systemic autoimmune disorder . 14 . Significant active systemic localize infection . 15 . Receiving immunosuppressant medication . 16 . Postradical prostatectomy .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Wharton jelly mesenchymal stem cell</keyword>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Diabetes</keyword>
</DOC>